The evolutionarily conserved leprecan gene

Its regulation by Brachyury and its role in the developing Ciona notochord

Matthew P. Dunn, Anna Di Gregorio

Research output: Contribution to journalArticle

Abstract

In Ciona intestinalis, leprecan was identified as a target of the notochord-specific transcription factor Ciona Brachyury (Ci-Bra) (Takahashi, H., Hotta, K., Erives, A., Di Gregorio, A., Zeller, R.W., Levine, M., Satoh, N., 1999. Brachyury downstream notochord differentiation in the ascidian embryo. Genes Dev. 13, 1519-1523). By screening ∼ 14 kb of the Ci-leprecan locus for cis-regulatory activity, we have identified a 581-bp minimal notochord-specific cis-regulatory module (CRM) whose activity depends upon T-box binding sites located at the 3′-end of its sequence. These sites are specifically bound in vitro by a GST-Ci-Bra fusion protein, and mutations that abolish binding in vitro result in loss or decrease of regulatory activity in vivo. Serial deletions of the 581-bp notochord CRM revealed that this sequence is also able to direct expression in muscle cells through the same T-box sites that are utilized by Ci-Bra in the notochord, which are also bound in vitro by the muscle-specific T-box activators Ci-Tbx6b and Ci-Tbx6c. Additionally, we created plasmids aimed to interfere with the function of Ci-leprecan and categorized the resulting phenotypes, which consist of variable dislocations of notochord cells along the anterior-posterior axis. Together, these observations provide mechanistic insights generally applicable to T-box transcription factors and their target sequences, as well as a first set of clues on the function of Leprecan in early chordate development.

Original languageEnglish (US)
Pages (from-to)561-574
Number of pages14
JournalDevelopmental Biology
Volume328
Issue number2
DOIs
StatePublished - Apr 15 2009

Fingerprint

Notochord
Genes
Transcription Factors
Ciona intestinalis
Chordata
Urochordata
Muscle Cells
Brachyury protein
Plasmids
Embryonic Structures
Binding Sites
Phenotype
Muscles
Mutation
In Vitro Techniques

Keywords

  • Ascidian
  • Brachyury
  • Ciona
  • cis-Regulation
  • Leprecan
  • Muscle
  • Notochord
  • Prolyl 3-hydroxylase
  • T-box
  • Tbx6

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Molecular Biology

Cite this

The evolutionarily conserved leprecan gene : Its regulation by Brachyury and its role in the developing Ciona notochord. / Dunn, Matthew P.; Di Gregorio, Anna.

In: Developmental Biology, Vol. 328, No. 2, 15.04.2009, p. 561-574.

Research output: Contribution to journalArticle

@article{beb66aac4d71415a88289228db477451,
title = "The evolutionarily conserved leprecan gene: Its regulation by Brachyury and its role in the developing Ciona notochord",
abstract = "In Ciona intestinalis, leprecan was identified as a target of the notochord-specific transcription factor Ciona Brachyury (Ci-Bra) (Takahashi, H., Hotta, K., Erives, A., Di Gregorio, A., Zeller, R.W., Levine, M., Satoh, N., 1999. Brachyury downstream notochord differentiation in the ascidian embryo. Genes Dev. 13, 1519-1523). By screening ∼ 14 kb of the Ci-leprecan locus for cis-regulatory activity, we have identified a 581-bp minimal notochord-specific cis-regulatory module (CRM) whose activity depends upon T-box binding sites located at the 3′-end of its sequence. These sites are specifically bound in vitro by a GST-Ci-Bra fusion protein, and mutations that abolish binding in vitro result in loss or decrease of regulatory activity in vivo. Serial deletions of the 581-bp notochord CRM revealed that this sequence is also able to direct expression in muscle cells through the same T-box sites that are utilized by Ci-Bra in the notochord, which are also bound in vitro by the muscle-specific T-box activators Ci-Tbx6b and Ci-Tbx6c. Additionally, we created plasmids aimed to interfere with the function of Ci-leprecan and categorized the resulting phenotypes, which consist of variable dislocations of notochord cells along the anterior-posterior axis. Together, these observations provide mechanistic insights generally applicable to T-box transcription factors and their target sequences, as well as a first set of clues on the function of Leprecan in early chordate development.",
keywords = "Ascidian, Brachyury, Ciona, cis-Regulation, Leprecan, Muscle, Notochord, Prolyl 3-hydroxylase, T-box, Tbx6",
author = "Dunn, {Matthew P.} and {Di Gregorio}, Anna",
year = "2009",
month = "4",
day = "15",
doi = "10.1016/j.ydbio.2009.02.007",
language = "English (US)",
volume = "328",
pages = "561--574",
journal = "Developmental Biology",
issn = "0012-1606",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - The evolutionarily conserved leprecan gene

T2 - Its regulation by Brachyury and its role in the developing Ciona notochord

AU - Dunn, Matthew P.

AU - Di Gregorio, Anna

PY - 2009/4/15

Y1 - 2009/4/15

N2 - In Ciona intestinalis, leprecan was identified as a target of the notochord-specific transcription factor Ciona Brachyury (Ci-Bra) (Takahashi, H., Hotta, K., Erives, A., Di Gregorio, A., Zeller, R.W., Levine, M., Satoh, N., 1999. Brachyury downstream notochord differentiation in the ascidian embryo. Genes Dev. 13, 1519-1523). By screening ∼ 14 kb of the Ci-leprecan locus for cis-regulatory activity, we have identified a 581-bp minimal notochord-specific cis-regulatory module (CRM) whose activity depends upon T-box binding sites located at the 3′-end of its sequence. These sites are specifically bound in vitro by a GST-Ci-Bra fusion protein, and mutations that abolish binding in vitro result in loss or decrease of regulatory activity in vivo. Serial deletions of the 581-bp notochord CRM revealed that this sequence is also able to direct expression in muscle cells through the same T-box sites that are utilized by Ci-Bra in the notochord, which are also bound in vitro by the muscle-specific T-box activators Ci-Tbx6b and Ci-Tbx6c. Additionally, we created plasmids aimed to interfere with the function of Ci-leprecan and categorized the resulting phenotypes, which consist of variable dislocations of notochord cells along the anterior-posterior axis. Together, these observations provide mechanistic insights generally applicable to T-box transcription factors and their target sequences, as well as a first set of clues on the function of Leprecan in early chordate development.

AB - In Ciona intestinalis, leprecan was identified as a target of the notochord-specific transcription factor Ciona Brachyury (Ci-Bra) (Takahashi, H., Hotta, K., Erives, A., Di Gregorio, A., Zeller, R.W., Levine, M., Satoh, N., 1999. Brachyury downstream notochord differentiation in the ascidian embryo. Genes Dev. 13, 1519-1523). By screening ∼ 14 kb of the Ci-leprecan locus for cis-regulatory activity, we have identified a 581-bp minimal notochord-specific cis-regulatory module (CRM) whose activity depends upon T-box binding sites located at the 3′-end of its sequence. These sites are specifically bound in vitro by a GST-Ci-Bra fusion protein, and mutations that abolish binding in vitro result in loss or decrease of regulatory activity in vivo. Serial deletions of the 581-bp notochord CRM revealed that this sequence is also able to direct expression in muscle cells through the same T-box sites that are utilized by Ci-Bra in the notochord, which are also bound in vitro by the muscle-specific T-box activators Ci-Tbx6b and Ci-Tbx6c. Additionally, we created plasmids aimed to interfere with the function of Ci-leprecan and categorized the resulting phenotypes, which consist of variable dislocations of notochord cells along the anterior-posterior axis. Together, these observations provide mechanistic insights generally applicable to T-box transcription factors and their target sequences, as well as a first set of clues on the function of Leprecan in early chordate development.

KW - Ascidian

KW - Brachyury

KW - Ciona

KW - cis-Regulation

KW - Leprecan

KW - Muscle

KW - Notochord

KW - Prolyl 3-hydroxylase

KW - T-box

KW - Tbx6

UR - http://www.scopus.com/inward/record.url?scp=63349087979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63349087979&partnerID=8YFLogxK

U2 - 10.1016/j.ydbio.2009.02.007

DO - 10.1016/j.ydbio.2009.02.007

M3 - Article

VL - 328

SP - 561

EP - 574

JO - Developmental Biology

JF - Developmental Biology

SN - 0012-1606

IS - 2

ER -